Search results for "" 2268 results found

• IP Cases & Articles

  Qatar Becomes PCT Contracting State

  Posted on 10 May 2011
  Qatar (QA) became the 143rd PCT Contracting State on 3 May 2011. The PCT will enter into force for that State on 3 August 2011.
• IP Cases & Articles

  The Hargreaves Review: Intellectual Property and Growth

  Posted on 01 June 2011
  Professor Ian Hargreaves has now completed his independent review of intellectual property and growth, commissioned by the UK government, and the report has been published.
• IP Cases & Articles

  T1854/07: plant varieties in European Patent Law

  Posted on 13 July 2011
  European patent EP-B-1 185 161 (which published as WO00/74469) had claims which were directed to sunflower seeds that contain a specific modified fatty acid composition obtainable by crossing a specific high stearic sunflower breeding line (CAS-3) with a high palmitic line and selecting seed of F2 generations in which the…
• IP Cases & Articles

  Universal Successor: T1421/05 and T0261/08

  Posted on 18 July 2011
  The circumstances in which the transfer of an opposition to a patent at the European Patent Office (EPO) can or should take place is an area where care is needed, particularly where an appeal is involved. The risk of getting a transfer wrong is that you lose your chance to…
• IP Cases & Articles

  Myriad: Association for Molecular Pathology

  Posted on 09 August 2011
  On 29 July 2011, the Federal Circuit issued its much anticipated decision on the ‘Myriad case’. The court held that that claims directed to isolated DNA were patent eligible but diagnostic claims that relate to ‘comparing’ or ‘analysing’ sequences were patent ineligible.
  

  Simon O'Brien

  Partner, Patent Attorney
• IP Cases & Articles

  Surgical Methods G1/07 ��� Tech Board of Appeal T0663/02

  Posted on 19 July 2011
  What is a 'surgical method'? In the wake of Enlarged Board of Appeal (EBA) decision G1/07 which supposedly provided clarity on this point, many patent attorneys have had sleepless nights when formulating claims which require a step of 'injecting' a compound into a subject.
• IP Cases & Articles

  Patenting Genes and Diagnostics

  Posted on 11 September 2011
  This article was originally published by Life Sciences Intellectual Property Review.
  

  Simon O'Brien

  Partner, Patent Attorney
• IP Cases & Articles

  MedImmune v Novartis: Obviousness and Lack of Priority��

  Posted on 03 October 2011
  The judgment by Mr Justice Arnold runs to 161 pages, and relates to a large family of patents jointly owned by MedImmune and MRC, which were directed to antibody phage display technology. Allegedly these patents were infringed by Novartis’ sale of Lucentis (chemically named ranibizumab), which is a treatment for…
• IP Cases & Articles

  CJEU Stem Cell Patents: Br��stle v Greenpeace (C-34/10)

  Posted on 18 October 2011
  The Court of Justice of the European Union (CJEU) today issued its decision in Brüstle v Greenpeace (C-34/10) which relates to the patentability of technology based on the use of human embryonic stem cells (hESC).
• IP Cases & Articles

  Generics UK (Mylan) v Novartis: EWHC 2403 Rivastigmine

  Posted on 21 October 2011
  The High Court has recently handed down judgment resulting in the revocation of the Novartis patent and SPC relating to rivastigmine (Exelon®). This is a further action where the Court was faced with a patent relating to the resolved enantiomer of a prior art racemic compound. Unlike the previous occasions,…

Page 110 of 227